HOPE Super Grant was awarded to Dr. Mitchell Cairo to support the development of new and improved ways to treat pediatric solid tumors

St. Baldrick’s Foundation shared on LinkedIn:

“For kids with osteosarcoma, a relapse is devastating, greatly reducing the chance for a cure. Thanks to the generosity of a group of St. Baldrick’s funding partners, the Helping Osteosarcoma Patients Everywhere (HOPE) Super Grant was awarded to Dr. Mitchell Cairo at New York Medical College in 2023.

This $1.5 million grant supports the development of new and improved ways to treat pediatric solid tumors by using immunotherapy, clever viruses, and combinations of treatments in clinical trials to help children with relapsed osteosarcoma.

Funding partners include: Battle Osteosarcoma, the Zach Sobiech Osteosarcoma Fund of Children’s Cancer Research Fund, The Faris Foundation, the Children’s Cancer Fund NY, which supports New York Medical College, and Nationwide Children’s Hospital.

Learn more about this groundbreaking research.”

Source: St. Baldrick’s Foundation/LinkedIn

Dr. Mitchell S. Cairo is a renowned pediatric hematologist and oncologist, serving as Chief of Pediatric Hematology, Oncology, and Stem Cell Transplantation, and Director of the Children and Adolescent Cancer and Blood Diseases Center at Maria Fareri Children’s Hospital at Westchester Medical Center.

His work focuses on cancer genetics, tumor immunology, transplantation biology, stem cell biology, and regenerative medicine. Dr. Cairo is a researcher and practicing physician at New York Medical College, with pioneering contributions in immunotherapy, gene therapy, and targeted treatments for leukemia and lymphoma.